Joseph Truitt, Director at Larimar Therapeutics, Inc. (LRMR), bought 2,750 shares at $3.73 ($10K) on 2023-05-17, disclosed to the SEC on 2023-05-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ACHN | SELL | 2014-08-26 | $271K | — | Filing → |
| ACHN | SELL | 2014-06-17 | $196K | — | Filing → |
| ACHN | SELL | 2014-06-11 | $301K | — | Filing → |